Published May 22, 2026
CBD Once Dominated the Hemp Industry
For years, CBD was almost entirely synonymous with the modern hemp industry.
After the 2018 Farm Bill expanded legal hemp production in the United States, CBD rapidly became one of the most recognizable cannabis-derived wellness products in the country. Oils, gummies, tinctures, capsules, beverages, and skincare products flooded the market as brands competed to establish themselves during the industry’s early expansion phase.
At the time, many companies marketed hemp products almost exclusively around CBD concentration itself. Product labels often emphasized large milligram counts while broader cannabinoid discussions remained relatively limited outside more experienced cannabis circles.
But in 2026, the hemp industry is beginning to look very different.
Many brands now market products containing additional cannabinoids such as CBG, CBN, CBC, and THCV as consumers become more familiar with hemp-derived compounds beyond CBD alone.
Consumers Are Becoming More Familiar With Cannabinoid Diversity
One reason for this shift is simple consumer education.
As cannabis and hemp products became more mainstream, consumers gradually learned that cannabis plants produce far more compounds than just THC and CBD. Research discussions, dispensary education, social media, podcasts, and product marketing all helped increase public awareness surrounding lesser-known cannabinoids.
Today, many hemp consumers recognize names like:
- CBG
- CBN
- CBC
- THCV
even if they do not fully understand how those compounds differ from one another.
That growing familiarity created new opportunities for hemp brands trying to stand out in an increasingly crowded marketplace.
Hemp Brands Are Trying to Differentiate Themselves
The CBD market became highly saturated during the past several years.
Thousands of companies entered the hemp industry during the initial CBD boom, creating intense competition around pricing, potency claims, and branding. As a result, many operators began searching for new ways to distinguish products beyond simply offering “more CBD.”
Minor cannabinoids provided a natural opportunity.
Instead of marketing generic CBD tinctures alone, companies increasingly developed products centered around:
- sleep-focused cannabinoid blends
- daytime formulations
- relaxation products
- focus-oriented formulas
- recovery products
This allowed brands to create more targeted product categories while also moving away from overly broad wellness marketing.
CBG and CBN Became Especially Popular
Some minor cannabinoids gained traction faster than others.
CBG, often called cannabigerol, became associated in marketing discussions with daytime use, clarity, and balanced formulations. CBN products, meanwhile, increasingly appeared in nighttime gummies and sleep-oriented hemp blends.
Many brands now combine cannabinoids together instead of relying on isolated CBD formulas alone. Consumers shopping for hemp products increasingly encounter formulations that combine:
- CBD
- CBG
- CBN
- terpene blends
- botanical ingredients
within the same product.
This trend mirrors broader supplement-industry behavior where products increasingly market combinations of ingredients instead of single compounds alone. Growing consumer interest in broader cannabinoid formulations also reflects increasing curiosity surrounding how cannabis compounds may interact together within full-spectrum products.
Product Labels Are Becoming More Complex
As hemp formulations diversified, packaging and labeling also became more detailed.
Consumers now regularly encounter products displaying:
- cannabinoid breakdown charts
- terpene profiles
- QR-linked lab reports
- extraction details
- THC compliance information
instead of simple CBD milligram counts alone.
This growing complexity reflects both increasing consumer education and rising skepticism surrounding vague hemp marketing claims. Many shoppers now spend more time researching formulations, Certificates of Analysis, and cannabinoid content before making purchases.
Modern hemp packaging increasingly resembles scientific supplement labeling rather than the simpler wellness-focused branding common during the early CBD boom.
Scientific Research Still Remains Limited
Despite growing commercial interest, research surrounding many minor cannabinoids remains relatively limited compared to CBD itself.
Some cannabinoids still lack extensive long-term human clinical data, and many product claims circulating online extend beyond what current research fully supports. This creates a difficult environment where marketing trends often move faster than scientific consensus.
As a result, regulators continue monitoring cannabinoid marketing language closely, especially when companies imply medical benefits without FDA approval.
For consumers, this means product education and realistic expectations remain important as newer cannabinoid categories continue expanding.
The Hemp Industry Is Becoming More Specialized
The broader hemp market increasingly resembles other modern wellness industries where consumers shop for highly specific experiences instead of generic products.
Rather than simply purchasing “CBD oil,” many consumers now seek products tailored toward:
- sleep routines
- stress management
- daytime use
- workout recovery
- focus
- relaxation
This specialization allows brands to target narrower consumer niches while also encouraging repeat purchasing behavior around specific formulations.
At the same time, it reflects a larger industry transition away from the early-era assumption that CBD alone would dominate hemp retail indefinitely.
Hemp Consumers Are Becoming More Sophisticated
The growth of minor cannabinoids reflects a broader maturation process happening across the hemp industry.
Early CBD markets often focused heavily on novelty and rapid expansion. But as consumers became more educated, purchasing behavior naturally evolved. Shoppers increasingly research formulations, compare cannabinoids, examine terpene profiles, and evaluate transparency before purchasing products.
In many ways, hemp consumers now behave more like supplement or wellness shoppers than participants in an emerging trend market.
For hemp brands, this creates both opportunity and pressure. Companies can develop more specialized product categories than ever before, but consumers also expect greater transparency, consistency, and product education as cannabinoid formulations continue becoming more complex.
Sources:
Project CBD – Informational
https://projectcbd.org/
Brightfield Group – Consumer Insights
https://www.brightfieldgroup.com/